Literature DB >> 27147661

Defects in Neuromuscular Transmission May Underlie Motor Dysfunction in Spinal and Bulbar Muscular Atrophy.

Youfen Xu1, Katherine Halievski1, Casey Henley1, William D Atchison1, Masahisa Katsuno2, Hiroaki Adachi3, Gen Sobue2, S Marc Breedlove1, Cynthia L Jordan4.   

Abstract

UNLABELLED: Spinal and bulbar muscular atrophy (SBMA) in men is an androgen-dependent neuromuscular disease caused by expanded CAG repeats in the androgen receptor (AR). Whether muscle or motor neuron dysfunction or both underlies motor impairment in SBMA is unknown. Muscles of SBMA mice show significant contractile dysfunction, implicating them as a likely source of motor dysfunction, but whether disease also impairs neuromuscular transmission is an open question. Thus, we examined synaptic function in three well-studied SBMA mouse models-the AR97Q, knock-in (KI), and myogenic141 models-by recording in vitro miniature and evoked end-plate potentials (MEPPs and EPPs, respectively) intracellularly from adult muscle fibers. We found striking defects in neuromuscular transmission suggesting that toxic AR in SBMA impairs both presynaptic and postsynaptic mechanisms. Notably, SBMA causes neuromuscular synapses to become weak and muscles to become hyperexcitable in all three models. Presynaptic defects included deficits in quantal content, reduced size of the readily releasable pool, and impaired short-term facilitation. Postsynaptic defects included prolonged decay times for both MEPPs and EPPs, marked resistance to μ-conotoxin (a sodium channel blocker), and enhanced membrane excitability. Quantitative PCR revealed robust upregulation of mRNAs encoding neonatal isoforms of the AChR (γ-subunit) and the voltage-gated sodium channel (NaV1.5) in diseased adult muscles of all three models, consistent with the observed slowing of synaptic potentials and resistance to μ-conotoxin. These findings suggest that muscles of SBMA patients regress to an immature state that impairs neuromuscular function. SIGNIFICANCE STATEMENT: We have discovered that SBMA is accompanied by marked defects in neuromuscular synaptic transmission involving both presynaptic and postsynaptic mechanisms. For three different mouse models, we find that diseased synapses are weak, having reduced quantal content due to reductions in the size of the readily releasable pool and/or probability of release. Synaptic potentials in diseased adult fibers are slowed, explained by an aberrant upregulation of the neonatal isoform of the acetylcholine receptor. Diseased fibers also show marked resistance to μ-conotoxin, explained by an aberrant upregulation in the neonatal isoform of the sodium channel, and are hyperexcitable, reminiscent of myotonic dystrophy, showing anode-break action potentials. This work identifies several new molecular targets for recovering function in SBMA.
Copyright © 2016 the authors 0270-6474/16/365094-13$15.00/0.

Entities:  

Keywords:  acetylcholine receptor; motor dysfunction; muscle excitability; neuromuscular transmission; spinal and bulbar muscular atrophy; synaptic vesicle

Mesh:

Substances:

Year:  2016        PMID: 27147661      PMCID: PMC4854970          DOI: 10.1523/JNEUROSCI.3485-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Cellular and molecular biology of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Physiol Rev       Date:  1992-10       Impact factor: 37.312

2.  Differential regulation of Na(v)beta subunits during myogenesis.

Authors:  Miren David; Ramón Martínez-Mármol; Teresa Gonzalez; Antonio Felipe; Carmen Valenzuela
Journal:  Biochem Biophys Res Commun       Date:  2008-02-07       Impact factor: 3.575

3.  Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

4.  Acetylcholine receptor gamma-subunits mRNA isoforms expressed in denervated rat muscle.

Authors:  Amanda M Li; Hualong Ma; Alfredo Villarroel
Journal:  Mol Neurobiol       Date:  2008-06-12       Impact factor: 5.590

5.  Synapsins as mediators of BDNF-enhanced neurotransmitter release.

Authors:  J N Jovanovic; A J Czernik; A A Fienberg; P Greengard; T S Sihra
Journal:  Nat Neurosci       Date:  2000-04       Impact factor: 24.884

6.  Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease.

Authors:  Douglas Ashley Monks; Jamie A Johansen; Kaiguo Mo; Pengcheng Rao; Bryn Eagleson; Zhigang Yu; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

7.  Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice.

Authors:  Rocío Ruiz; Juan José Casañas; Laura Torres-Benito; Raquel Cano; Lucía Tabares
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

8.  Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.

Authors:  Shingo Kariya; Gyu-Hwan Park; Yuka Maeno-Hikichi; Olga Leykekhman; Cathleen Lutz; Marc S Arkovitz; Lynn T Landmesser; Umrao R Monani
Journal:  Hum Mol Genet       Date:  2008-05-20       Impact factor: 6.150

9.  Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.

Authors:  Lingling Kong; Xueyong Wang; Dong W Choe; Michelle Polley; Barrington G Burnett; Marta Bosch-Marcé; John W Griffin; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

10.  Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses.

Authors:  Pietro Baldelli; Anna Fassio; Flavia Valtorta; Fabio Benfenati
Journal:  J Neurosci       Date:  2007-12-05       Impact factor: 6.167

View more
  13 in total

1.  Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.

Authors:  Jessica E Poort; Mary B Rheuben; S Marc Breedlove; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2016-08-04       Impact factor: 6.150

2.  Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.

Authors:  Anna Pluciennik; Yuhong Liu; Elana Molotsky; Gregory B Marsh; Bedri Ranxhi; Frederick J Arnold; Sophie St-Cyr; Beverly Davidson; Naemeh Pourshafie; Andrew P Lieberman; Wei Gu; Sokol V Todi; Diane E Merry
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 3.  Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

Authors:  Caterina Marchioretti; Emanuela Zuccaro; Udai Bhan Pandey; Jessica Rosati; Manuela Basso; Maria Pennuto
Journal:  Cells       Date:  2022-07-03       Impact factor: 7.666

4.  Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.

Authors:  Youfen Xu; Katherine Halievski; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; S Marc Breedlove; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

5.  Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.

Authors:  Vladimir A Martínez-Rojas; Daniele Arosio; Maria Pennuto; Carlo Musio
Journal:  Pflugers Arch       Date:  2021-05-22       Impact factor: 3.657

Review 6.  The Regulation of the Small Heat Shock Protein B8 in Misfolding Protein Diseases Causing Motoneuronal and Muscle Cell Death.

Authors:  Riccardo Cristofani; Paola Rusmini; Mariarita Galbiati; Maria Elena Cicardi; Veronica Ferrari; Barbara Tedesco; Elena Casarotto; Marta Chierichetti; Elio Messi; Margherita Piccolella; Serena Carra; Valeria Crippa; Angelo Poletti
Journal:  Front Neurosci       Date:  2019-08-02       Impact factor: 4.677

7.  Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Elena Cicardi; Riccardo Cristofani; Valeria Crippa; Veronica Ferrari; Barbara Tedesco; Elena Casarotto; Marta Chierichetti; Mariarita Galbiati; Margherita Piccolella; Elio Messi; Serena Carra; Maria Pennuto; Paola Rusmini; Angelo Poletti
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-20       Impact factor: 5.555

8.  The effect of NAMPT deletion in projection neurons on the function and structure of neuromuscular junction (NMJ) in mice.

Authors:  Samuel Lundt; Nannan Zhang; Xiaowan Wang; Luis Polo-Parada; Shinghua Ding
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

9.  Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.

Authors:  Anna L Gray; Leonette Annan; James R T Dick; Albert R La Spada; Michael G Hanna; Linda Greensmith; Bilal Malik
Journal:  Dis Model Mech       Date:  2020-05-26       Impact factor: 5.758

Review 10.  Cell-Clearing Systems Bridging Repeat Expansion Proteotoxicity and Neuromuscular Junction Alterations in ALS and SBMA.

Authors:  Fiona Limanaqi; Carla Letizia Busceti; Francesca Biagioni; Federica Cantini; Paola Lenzi; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.